Literature DB >> 28499981

Mitochondrial dysfunction in ocular disease: Focus on glaucoma.

Khalid Kamel1, Michael Farrell2, Colm O'Brien3.   

Abstract

Mitochondrial dysfunction commonly presents with ocular findings as a part of a systemic disorder. These ophthalmic manifestations can be the first sign of a mitochondrial abnormality, which highlights the key role of a comprehensive ophthalmic assessment. On the other hand, a number of visually disabling genetic and acquired eye diseases with no curative treatment show abnormal mitochondrial function. Recent advances in mitochondrial research have improved our understanding of previously unexplained ocular disorders utilising better diagnostic approaches. Further studies on mitochondrial dysfunction and novel modalities of treatment will help to improve outcomes of these conditions. In this review article we discuss the clinical picture of common mitochondrial-related eye diseases, diagnostic approaches and possible treatment options including a very recent interesting report about gene therapy, with a particular focus on glaucoma.
Copyright © 2017 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Glaucoma; Mitochondria; Oxidative stress; mtDNA

Mesh:

Year:  2017        PMID: 28499981     DOI: 10.1016/j.mito.2017.05.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  23 in total

1.  Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients.

Authors:  Huiyuan Hou; Takuhei Shoji; Linda M Zangwill; Sasan Moghimi; Luke J Saunders; Kyle Hasenstab; Elham Ghahari; Patricia Isabel C Manalastas; Tadamichi Akagi; Mark Christopher; Rafaella C Penteado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2018-02-13       Impact factor: 5.258

2.  Racial Disparities in Glaucoma: From Epidemiology to Pathophysiology.

Authors:  Carla J Siegfried; Ying-Bo Shui
Journal:  Mo Med       Date:  2022 Jan-Feb

3.  Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model.

Authors:  Shouyue Huang; Ping Huang; Xi Shen; Yisheng Zhong; Huan Yu; Junjue Chen; Xiaohong Liu; Jing Wang
Journal:  Cell Tissue Res       Date:  2022-05-20       Impact factor: 4.051

Review 4.  Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2017-12-01

Review 5.  Annexins in Glaucoma.

Authors:  Timothy E Yap; Benjamin Michael Davis; Li Guo; Eduardo M Normando; Maria Francesca Cordeiro
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

6.  Ultrastructural Morphology of the Optic Nerve Head in Aged and Glaucomatous Mice.

Authors:  Ying Zhu; Anthony C Pappas; Rui Wang; Philip Seifert; Daniel Sun; Tatjana C Jakobs
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

7.  A comparative map of macroautophagy and mitophagy in the vertebrate eye.

Authors:  Thomas G McWilliams; Alan R Prescott; Beatriz Villarejo-Zori; Graeme Ball; Patricia Boya; Ian G Ganley
Journal:  Autophagy       Date:  2019-02-20       Impact factor: 16.016

8.  DNAJC30 biallelic mutations extend mitochondrial complex I-deficient phenotypes to include recessive Leber's hereditary optic neuropathy.

Authors:  Janey L Wiggs
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 9.  Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence.

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2021-06-06       Impact factor: 5.717

10.  Targeted Delivery of Mitochondrial Calcium Channel Regulators: The Future of Glaucoma Treatment?

Authors:  Leanne T Y Cheung; Abby L Manthey; Jimmy S M Lai; Kin Chiu
Journal:  Front Neurosci       Date:  2017-11-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.